Search research articles
Contact Us
Filters
Showing results (11-20 of 126) with videos related to
Page
of 13
Sort By:
Onkologie
|
February 1, 2007
Fatal leukoencephalopathy after reduced-intensity allogeneic stem cell transplantation
Stephan Mielke, Karin Potthoff, Friedrich Feuerhake, et al.
Ejhaem
|
December 5, 2022
Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage-specific chimerism analysis
Hannes Lindahl, Davide Valentini, Sofie Vonlanthen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2005
Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer
Stephan Mielke, Alex Sparreboom, Seth M Steinberg, et al.
Frontiers in Immunology
|
October 10, 2022
T cell receptor excision circles are potential predictors of survival in adult allogeneic hematopoietic stem cell transplantation recipients with acute myeloid leukemia
Anna Söderström, Sofie Vonlanthen, Kerstin Jönsson-Videsäter, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2006
Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia
Tristan M Sissung, Klaus Mross, Seth M Steinberg, et al.
Journal of Clinical Microbiology
|
May 8, 2009
Life-threatening infection caused by daptomycin-resistant Corynebacterium jeikeium in a neutropenic patient
Christoph Schoen, Christian Unzicker, Gernot Stuhler, et al.
Anti-Cancer Drugs
|
November 5, 2003
Comparative neurotoxicity of weekly non-break paclitaxel infusions over 1 versus 3 h
Stephan Mielke, Klaus Mross, Thomas A Gerds, et al.
ALTEX
|
May 16, 2016
A first vascularized skin equivalent as an alternative to animal experimentation
Florian Groeber, Lisa Engelhardt, Julia Lange, et al.
Blood
|
April 7, 2007
High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects
Agnes S M Yong, Katayoun Rezvani, Bipin N Savani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2002
Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusions
Hans Gelderblom, Klaus Mross, Albert J ten Tije, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 126) with videos related to
Sort By:
Page
of 13
Onkologie
|
February 1, 2007
Fatal leukoencephalopathy after reduced-intensity allogeneic stem cell transplantation
Stephan Mielke, Karin Potthoff, Friedrich Feuerhake, et al.
Ejhaem
|
December 5, 2022
Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage-specific chimerism analysis
Hannes Lindahl, Davide Valentini, Sofie Vonlanthen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2005
Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer
Stephan Mielke, Alex Sparreboom, Seth M Steinberg, et al.
Frontiers in Immunology
|
October 10, 2022
T cell receptor excision circles are potential predictors of survival in adult allogeneic hematopoietic stem cell transplantation recipients with acute myeloid leukemia
Anna Söderström, Sofie Vonlanthen, Kerstin Jönsson-Videsäter, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2006
Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia
Tristan M Sissung, Klaus Mross, Seth M Steinberg, et al.
Journal of Clinical Microbiology
|
May 8, 2009
Life-threatening infection caused by daptomycin-resistant Corynebacterium jeikeium in a neutropenic patient
Christoph Schoen, Christian Unzicker, Gernot Stuhler, et al.
Anti-Cancer Drugs
|
November 5, 2003
Comparative neurotoxicity of weekly non-break paclitaxel infusions over 1 versus 3 h
Stephan Mielke, Klaus Mross, Thomas A Gerds, et al.
ALTEX
|
May 16, 2016
A first vascularized skin equivalent as an alternative to animal experimentation
Florian Groeber, Lisa Engelhardt, Julia Lange, et al.
Blood
|
April 7, 2007
High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects
Agnes S M Yong, Katayoun Rezvani, Bipin N Savani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2002
Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusions
Hans Gelderblom, Klaus Mross, Albert J ten Tije, et al.
Page
of 13